The renin-angiotensen system has long been recognized to play a major physiological role in regulating systemic blood pressure and fluid/electrolyte homeostasis. Renin, an aspartyl protease produced and secreted by the juxtaglomerular cells of the kidney, initiates an enzymatic cascade which results in the production of the vasoactive peptide angiotensin II, the major effector molecule of the renin-angiotensen system. Juxtaglomerular cells are modified smooth muscle cells located at the distal end of the afferent arteriole and in the normal mature kidney represent Ͻ.1% of the total kidney cell population (1) . Under normal physiological conditions, juxtaglomerular cells are the principal source of active renin found in the circulation (2, 3) . In addition to kidney, there are several extra-renal sites of renin mRNA expression (4) .
Some mouse strains have only a single renin gene (Ren-1 c ) whereas other strains have two copies (Ren-1 d and Ren-2) (5, 6). All these mouse renin genes are approximately equivalently expressed in juxtaglomerular cells, however, their expression is differentially regulated in some extra-renal tissues (7) .
A number of transgenic studies have presented compelling evidence suggesting that sequences regulating the tissue, cell, and developmental expression of mouse renin are located between 2.5 and 4.6 kb 1 upstream of the transcription start site of the Ren-2 gene (8, 9) . More recently, studies employing a Ren-1 c -GFP transgenic reporter have indicated that the major sequences required to correctly specify Ren-1 c expression spatially and temporally within embryonic, extra-embryonic and adult tissues, and in response to physiological perturbation of angiotensin II signaling, are resident within 4.1 kb of the immediate 5Ј-flanking sequence (45) .
A kidney-derived renin expressing cell line (As4.1), developed from a mouse strain containing only a single renin gene by transgene-targeted oncogenesis (11) , facilitates the identification of important cis-acting regulatory sequences controlling renin gene expression. Consistent with results from transgenic studies, transient transfection analysis of renin-chloramphenicol acetyltransferase reporter gene constructs have demonstrated that sequences located Ͼ2.6 kb upstream of the transcription start site are necessary for high level reporter gene expression (10) . In these studies, renin promoter (Ϫ117 to ϩ6) CAT constructs containing 5Ј-flanking sequence extending to Ϫ2.6 kb did not increase basal transcriptional activity. However, promoter constructs containing 4.0 kb of upstream se-quence (Ϫ4,100 to Ϫ117) increased transcriptional activity ϳ2 orders of magnitude. Progressive deletion analysis localized equivalent activity to a 242-bp fragment (Ϫ2866 to Ϫ2625). This fragment acts as a classical enhancer of transcription, stimulating promoter activity Ͼ50-fold in an orientation and position independent fashion. Sequences showing ϳ98% sequence identity to the Ren-1 c enhancer have been identified in the 5Ј-flanking regions of Ren-2 and Ren-1 d . 2 Significantly, recent studies have identified a sequence homologous to the mouse enhancer ϳ12 kb upstream of the human renin gene (12, 13) . The high degree of enhancer homology in the mouse renin genes and the cross-species conservation suggests that this region plays an important role in regulating renin gene transcription.
Despite the high degree of sequence similarity, the mouse and human enhancers differ in their ability to activate transcription of a renin promoter. With respect to the transcription start site, the distal 202 bp of the mouse and human sequences demonstrate a higher degree of homology (80%) than the more proximal 40 bp (45%) (12, 13) . Recent studies with chimeric enhancers have demonstrated that the functional difference between the mouse and human enhancers is due to sequence differences in the proximal 40 bp (13) . Electrophoretic mobility shift assays (EMSAs) detected sequence-specific binding to two overlapping elements, Ea and Eb, within the proximal 40 bp of the mouse enhancer. Mutagenesis and transfection analysis revealed that the higher transcriptional activity observed with the mouse enhancer is due to the stimulating effects of element Eb, whereas element Ea antagonizes the positive influence of element Eb. In addition, the 40-bp element does not stimulate basal promoter activity on its own, suggesting that additional upstream sequences within the 202-bp distal sequence are also necessary for full transcriptional activity. A direct repeat of Eb, named Ec, has been localized upstream of the 40-bp element and 10 bp from Eb (14) . Both Eb and Ec are important for the basal expression of the mouse renin gene and bind the retinoic acid receptor and retinoic X receptor to confer retinoic acid activation.
Here we report the further delimitation and characterization of cis-acting elements in the distal 202 bp of the mouse Ren-1 c enhancer. Our results indicate that a CRE-like element and an E-box are required for the enhancer activity. Moreover, CREB/ CREM and USF1/USF2 are identified as transcription factors in As4.1 cells binding to these two sequences, respectively. Mutation of either the CRE or E-box nearly abolishes Ren-1 c expression, supporting the critical roles these elements play in regulating renin gene transcription. Also, our results suggest that the high basal level of renin gene expression in As4.1 cells is probably the result of constitutive activation of PKA and that the Ren-1 c CRE is a target sequence for the cAMP/PKA pathway.
EXPERIMENTAL PROCEDURES
Plasmid Construction-Plasmid 117R1 was constructed by inserting a 123-bp fragment containing Ren-1 c peomoter sequence from Ϫ117 to ϩ6 into BglII/HindIII sites in pGL2-basic (Promega). Plasmid 2866/2625 containing intact Ren-1 c enhancer fused to the promoter region was prepared by inserting the BamHI-digested enhancer fragment from plasmid Ϫ117CAT(Ϫ2866 to Ϫ2625) (10) into the BglII site in 117R1 in correct orientation. All 5Ј deletion mutants of Ren-1 c enhancer in Fig. 1A were constructed by inserting the corresponding polymerase chain reaction synthesized fragments containing truncated enhancer plus the promoter region into SacI/ HindIII sites in pGL2-basic. Those 3Ј enhancer deletion mutants in Fig. 1B contain polymerase chain reaction-synthesized truncated enhancer fragments inserted into SacI/BglII sites in 117R1. Plasmids 117R1CEC, 117R1mCEC, 117R1CmEC, and 117R1CEmC were constructed by inserting oligonucleotides containing wild-type Ren-1 c enhancer sequence from Ϫ2702 to Ϫ2663 (CEC), CRE-mutated CEC, E-box-mutated CEC, and Ec-mutated CEC into SacI/BglII sites in 117R1. Plasmid 2625 was constructed by inserting an XhoI-BglIISphI linker into XhoI/SphI-digested pGL2-basic to create pGL-XBS, and then by inserting a SphI fragment containing Ren-1 c sequence from Ϫ2625 to ϩ6 from plasmid Ϫ4.1R1 (48) into SphI-digested pGL-XBS. The XhoI/BglII-digested polymerase chain reaction fragments containing Ren-1 c enhancer and site specifically mutated enhancers including Ea, Eb, Ec, Ea ϩ Eb, E-box, CRE, and E-box ϩ CRE mutations were inserted into XhoI/BglII sites in 2625 to create 2625enh, 2625enh/ma, 2625enh/mb, 2625enh/mc, 2625enh/mbc, 2625enh/me, 2625enh/mcre, and 2625enh/mce, respectively. All these enhancers containing mutated sites were also inserted into SacI/ BglII sites in 117R1 to create 117enh, 117enh/ma, 117enh/mb, 117enh/mc, 117enh/mbc, 117enh/me, 117enh/mcre, and 117enh/mce, respectively. Plasmid 117R1-CRE4 was constructed by inserting an oligonucleotide containing four copies of the Ren-1 c CRE into SacI/ BglII sites of 117R1. Enh-TA and Enh/mcre-TA were constructed by inserting the Ren-1 c enhancer and CRE-mutated enhancer, respectively, into SacI/BgII sites in a pGL2-basic-derived plasmid containing the adenovirus E1b TATA box (46) . Plasmid SSCRE contains the somatostatin promoter and consensus CRE in pGL2-basic (47) . Fulllength cDNA for USF1 was isolated by reverse transcriptasepolymerase chain reaction from As4.1 cells and cloned into BamHI/ EcoRI sites in pcDNA3.1/myc-His(ϩ)A vector (Invitrogen) without incorporating any epitope Tag. Sequences of all plasmid DNAs were verified by automated sequencing at the Roswell Park biopolymer facility.
Cell Culture and Transfection-The generation and characterization of the renin expressing As4.1 cell line (ATCC CRL2193) was previously described (11) . Both As4.1 and JEG-3 cells were propagated in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and transfected using FuGENE 6 (Roche Molecular Biochemicals). For each transfection in a 35-mm culture dish, 2.2 g of DNA including 0.5 g of reporter plasmid, 0.5 g of expression plasmid if needed, nonspecific plasmid, and 0.2 g of plasmid containing Rous sarcoma virus promoter driving ␤-galactosidase (RSV-␤gal) were mixed with 4.4 l of FuGENE reagent. Twenty-four h after transfection cells were harvested and measured for luciferase (Luc) and ␤-galactosidase activities using the Luciferase Assay System (Promega) and Galacto-Light Plus TM chemiluminescent reporter assay (Tropix), respectively. In Figs. 11 and 12, 2 g of reporter plasmid were used in each transfection assay and cells were harvested 48 h after transfection. Forskolin (10 M) and H-89 (10 M) were added 24 h prior to harvesting. The Luc activity is normalized with ␤-galactosidase activity to correct differences in transfection efficiency between experiments. All transfection results represent the average ϩ S.E. of at least three separate experiments.
EMSA-The EMSAs were performed as previously described (10) . For each reaction (10 l), labeled DNA probe (20,000 cpm) was mixed with about 6 g of nuclear extracts and 1 g of poly(dI-dC) in 10 mM Hepes, pH 7.9, 10 mM KCl, 50 mM NaCl, 2 mM MgCl 2, 1 mM EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10% glycerol. When oligonucleotide containing E-box was used as probe, 1 g of nonspecific competitor polydG⅐polydC was chosen instead of poly(dI-dC). Reaction mixture was incubated on ice for 15 min and then run on 5% polyacrylamide gel in 0.5 ϫ Tris borate-EDTA buffer. After electrophoresis at room temperature, the gels were dried for autoradiography. In a competition or supershift assay, an excess amount of unlabeled DNA or 1 l of antibody was added to reaction mixture 15 min or 1 h, respectively, prior to the addition of labeled DNA probe. Antibodies against CREB-1, CREB-2, ATF-1, ATF-2, ATF-3, CREM, c-JUN, USF1, USF2, and c-MYC were purchased from Santa Cruz Biotechnology, Inc.
In Vitro Transcription and Translation-Transcription factor USF1 was in vitro transcribed/translated by TNT-coupled wheat germ system (Promega). Two microliters of reaction were used in each EMSA.
Northern Blot Analysis-As4.1 cells were either untreated or treated with 10 M H-89 for 24 h. Total RNA was isolated by TRIZOL reagent (Life Technologies, Inc.), separated on 1.5% agarose formaldehyde gels, transferred to nitrocellulose membrane, and hybridized as described (49) . Radioactive signals from blots were quantified by phosphorimagery. As4. 1 Cells-Using a renin expressing kidney-derived tumoral cell line (As4.1) we have previously identified a 242-bp renin enhancer (coordinates Ϫ2866 to Ϫ2625 relative to the transcription start site) which activates transcription Ͼ50-fold in combination with the renin proximal promoter (Ϫ117 to ϩ6) (10) . In an effort to more precisely define sequence motifs necessary for high level gene expression, a series of 5Ј-deleted fragments of the Ren-1 c enhancer sequence were fused to a renin proximal promoter-Luc reporter gene construct (Ϫ117R1) (Fig. 1A) and assayed for activities after transient transfection into As4.1 cells (Fig. 1B) . Deletions of sequences from Ϫ2866 to Ϫ2699 result in about a 10-fold decrease in enhancer activity. Regions from Ϫ2829 to Ϫ2803, Ϫ2777 to Ϫ2751, Ϫ2738 to Ϫ2712, and Ϫ2712 to Ϫ2699 contribute to the enhancer activity by about 1.6-, 1.4-, 1.6-, and 3.0-fold, respectively. However, deletion of sequence from Ϫ2699 to Ϫ2684 results in a dramatic drop (10-fold) in the enhancer activity, suggesting that the sequence within the region from Ϫ2699 to Ϫ2684 is critical for maximal enhancer activity.
RESULTS

Delimiting Enhancer Regions Necessary for High Level Reporter Gene Expression in
To further localize sequences 3Ј to Ϫ2684 which are important for the enhancer activity, a series of 3Ј deletion mutants of enhancer were fused to Ϫ117R1 ( Fig. 2A) . Deletion of sequence from Ϫ2625 to Ϫ2663, which contains Ea and Eb sites (13), does not significantly affect the enhancer activity (Fig. 2B) . However, removal of Ec site (14) causes 6-fold reduction in activity. Further deletion from Ϫ2672 to Ϫ2684 results in another 6-fold decrease in activity, suggesting that this region may contain a protein-DNA interaction site. Consistent with results from 5Ј deletion mutants, deletion of sequence from Ϫ2684 to Ϫ2699 results in almost complete loss of enhancer activity.
Sequence from Ϫ2699 to Ϫ2684 Contains a CRE-like Element, Which Binds CREB/CREM-To identify the DNA-protein interaction site between Ϫ2699 to Ϫ2684, we employed EMSA using double stranded oligonucleotides containing 21 bp of renin enhancer sequence, Ϫ2702 to Ϫ2682 (oligonucleotide 1 c in Fig. 3A ), and nuclear extracts prepared from As4.1 cells (Fig. 3B ). These studies demonstrated the formation of a single complex (Fig. 3B , lane 1) which was efficiently competed with 50-fold molar excess of unlabeled oligonucleotide (lane 2). To more precisely define the specific base pairs critical for complex formation, competition was performed using six double stranded mutant oligonucleotides each containing sequential 3-bp mutations. Mutants CM1, CM2, CM3, and CM4 (Fig. 3B , lanes 3-6) were unable to effectively compete the DNA-protein interaction. However, mutants CM5 and CM6 (Fig. 3B , lanes 7-8) effectively competed complex formation. These results suggest that the DNA-protein interaction is confined to the sequence motif AATGACATCACT.
Search of the transcription factor data base identified an 8-bp sequence within this motif which showed significant similarity (7/8 bp match) to a consensus CRE. While the consensus CRE is defined by the palindromic sequence TGACGTCA (15-18), the majority of CREs identified thus far deviate from the consensus sequence by one or more base pairs (19) . The sequence identified in the renin enhancer is TGACATCA. To further investigate the potential role of this CRE-like element in the DNA-protein interaction(s) observed during EMSA with As4.1 nuclear extracts, we performed competition assays using double stranded oligonucleotides containing consensus CRE and mutated CRE sequences (Fig. 4A) . When the 21-bp renin oligonucleotide was used as a probe, a single complex was formed (Fig. 4B, lane 1) and was efficiently competed by increasing molar excess (ϫ25, ϫ50, ϫ100) of both unlabeled renin (lanes 2, 3, and 4) and consensus CRE (lanes 5, 6, and 7) oligonucleotides. The mutated CRE oligonucleotide (Fig. 4B,  lanes 8, 9, and 10) , however, was unable to effectively compete complex formation. In a reciprocal experiment, the consensus CRE oligonucleotide was labeled and used in EMSA with As4.1 nuclear extracts. This experiment also revealed a single complex (Fig. 4C, lane 1) which was efficiently competed by increasing molar excess (ϫ25, ϫ50, ϫ100) of both unlabeled CRE (lanes 2, 3, and 4) and renin (lanes 5, 6, and 7) oligonucleotides. The mutated CRE oligonucleotide (Fig. 4C, lanes 8, 9, and 10 ) was again incapable of competing the DNA-protein interaction. These experimental data suggest that complex formation is mediated by a CRE-like element.
CREs are known to form DNA⅐protein complexes with the ATF/CREB family of transcription factors. Although each of these proteins can bind to CRE as homodimers, some of these proteins can bind to CRE as heterodimers, both within the family and with members of the AP-1 transcription family (20) . To identify the specific nuclear factors that contribute to the DNA⅐protein complex observed with the renin CRE-like element and As4.1 nuclear extracts, we performed EMSAs using antibody against CREB-1 (Fig. 5A) . The results showed that addition of this antibody almost completely abolished the formation of As4.1 nuclear proteins⅐1 c complex. The CREB-1 antibody used can also react to ATF-1 and CREM. However, antibodies against ATF-1 and other transcription factors including CREB-2, ATF-2, ATF-3, and c-JUN did not attenuate or supershift the complex (Fig. 5B) . Addition of anti-CREM-1 antibody resulted in a partially supershifted complex (Fig. 5B,  lane 6) , indicating that the CREM transcription factor(s) can also bind to this site. These results demonstrate that the CRElike sequence located between Ϫ2699 and Ϫ2684 is a CREB/ CREM-binding site.
To determine whether CREB/CREM can activate gene expression by binding to this CRE-like element, a construct containing four copies of this element fused to 117R1 was transfected into As4.1 cells. Addition of Ren-1 c CREs resulted in almost 50-fold increase in transcription (Fig. 6) . Moreover, the induction was reduced 4-fold by co-transfecting cells with a dominant negative CREB (A-CREB) (21), further suggesting involvement of CREB/ATF transcription factors in renin gene regulation.
Sequence from Ϫ2684 to Ϫ2672 Contains an E-box, Which Binds USF1/USF2-Sequence from Ϫ2684 to Ϫ2672, which is required for the full enhancer activity, contains an E-box motif (CAGATG). To determine whether this E-box binds nuclear proteins in As4.1 cells, an oligonucleotide RE containing the E-box motif was used in EMSA (Fig. 7A) . A complex was formed with polydG⅐polydC as nonspecific competitor (Fig. 7B, lane 1) but not with poly(dI-dC) (data not shown). This complex is RE-specific since it was competed by 100-fold excess of RE itself but not by an oligonucleotide mRE containing a mutated E-box (Fig. 7B, lanes 2 and 3) . Also, the E-box complex was effectively competed with 100-fold molar excess of an oligonucleotide containing a USF1-binding site but not with a similar oligonucleotide containing a mutated USF1-binding site (Fig. 7C) .
To examine whether the bHLH-leucine zipper transcription factors USF1/USF2 bind to the Ren-1 c enhancer E-box, antibodies against USF1 and USF2 were used in supershift EMSA (Fig. 7D) . To separate the USF1/USF2 homodimers and heterodimer in EMSA, the specific RE/As4.1 nuclear extract complex shown in Fig. 7 , B and C, was run considerately further into the gel. At least two complexes (L and S) were observed (Fig. 7D, lane 1) . Addition of an increasing amount of antibody against USF1 gradually attenuated both the L and S bands (Fig. 7D, lanes 2-6) and the formation of both L and S complexes was completely abolished with more than 0.5 l of USF1 antiserum (Fig. 7D, lanes 4 -6) . Addition of 1 l of USF2 antiserum almost completely disrupted the formation of the S complex (Fig. 7D, lane 7) , whereas antibody against c-MYC, which recognizes a similar E-box sequence, did not disrupt the formation of either the L or S complex (Fig. 7D, lane 8) . These results suggest that the S band most probably contains the USF1/USF2 heterodimer whereas the L band contains the USF1 homodimer. Considering that USF1 has lower molecular weight than USF2, the USF1 homodimer would move faster than the USF1/USF2 heterodimer in the gel. Thus, the USF1 homodimer in the L band is probably associated with other unidentified proteins. In addition, given the decrease in intensity of the L band in response to antibody against USF2 (Fig.  7D, lane 7) , the L band may also contain USF1/USF2 heterodimer associated with other proteins. In vitro synthesized USF1 protein was able to bind to the RE probe (Fig. 7E, lane 3) , and the binding was completely abolished by the addition of USF1 antibody (Fig. 7E, lane 4) . These results suggest a potential role for the USF transcription factors in regulation of renin gene expression.
Synergistic Activation of Transcription by CRE and E-boxSince the progressive deletion experiments indicated that CRE, E-box, and Ec in the Ren-1
c enhancer are all required for the enhancer activity, we wanted to test whether these sites cooperatively activate gene expression. A construct containing enhancer sequence from Ϫ2702 to Ϫ2663 (see Fig. 8 for positions of various regulatory elements), which includes CRE, E-box, and Ec motifs, fused to 117R1 (Fig. 9A) , was transfected into A, sequences of the double stranded oligonucleotides used in EMSA: RE is the wild type renin sequence (coordinates Ϫ2688 to Ϫ2669) containing an E-box motif (indicated by a solid line), mRE contains selectively altered bases (indicated by underlined lowercase letters) within the E-box motif. USF1 is an oligonucleotide containing a consensus USF1 binding element (indicated by a solid line), mUSF1 is an oligonucleotide containing a mutated USF1 element (mutated base pairs indicated by underlined lowercase letters). B and C, oligonucleotide RE was used as probe in EMSA without competitor (Ϫ lane) or competed 100-fold molar excess of unlabeled oligonucleotides as indicated. Nuclear extracts were prepared from As4.1 cells. D, supershift EMSA was performed using RE as probe, As4.1 cell nuclear proteins and antibodies against USF1 (␣USF1), USF2 (␣USF2), and c-MYC (␣MYC). The Ϫ lane indicates no antibody added. An increasing amount of antibody against USF1 (0.125, 0.25, 0.5, 1, and 2 l) was added in lanes 2-6, respectively. Antibodies against USF2 (lane 7) and c-MYC (lane 8) were added 1 l each. The nonspecific complex (NS) and free probe (FP) are not shown. E, EMSA was performed on the RE probe using in vitro synthesized USF1. Lanes labeled with Lys contain the in vitro transcription/translation lysate without any DNA added. Antibody against USF1 (␣USF1) was used to supershift or attenuate the DNA⅐protein complex. The nonspecific binding by proteins from lysate is indicated by Lys and an arrow. The specific complex formed with As4.1 cell nuclear extract or USF1 protein and RE is indicated by an arrow. Nonspecific binding with RE and As4.1 nuclear proteins is indicated by NS. Free probe is indicated by FP.
As4.1 cells. This construct activates luciferase expression 29-fold over 117R1 (Fig. 9B) . However, similar constructs containing either mutated CRE or mutated E-box (Fig. 8) was not capable of activating the Ren-1 c promoter whereas a construct containing mutated Ec was still able to activate the promoter activity by almost 7-fold. These results suggest that CRE and E-box activate transcription cooperatively. Although Ec clearly participates in activity of the enhancer, loss of this binding site still retains some activity suggesting it may not be obligatorily required.
CRE and E-box Elements Are Crucial for Enhancer Activity and Gene Expression of the Mouse Ren-1
c Gene-To test how important the CRE, E-box, and other sites are in regulating Ren-1 c enhancer activity, a series of constructs were made based on 117R1enh (enhancer sequence from Ϫ2866 to Ϫ2625 fused 5Ј to 123 bp Ren-1 c promoter) and contain point mutations in CRE, E-box, Ec, Eb, and Ea motifs (Fig. 8) . These constructs were transfected into As4.1 cells and analyzed for their expression capabilities (Fig. 10A) . Mutation of Ea did not significantly change expression while mutation of Eb resulted in a 40% decrease in activity. Mutation of either Ec or the E-box reduced expression by 90%. The CRE element was a crucial regulatory site in the enhancer since mutation of the CRE site resulted in 97% reduction in enhancer activity. Mutations of both CRE and E-box caused almost complete loss of enhancer activity.
We then placed wild-type and site-specifically mutated Ren-1 c enhancer (Ϫ2866 to Ϫ2625) at Ϫ2625 bp. This permitted testing how mutations of these regulatory sites in their natural context would affect the Ren-1 c gene expression. A construct containing only 2625 bp of Ren-1 c 5Ј-flanking sequences fused to Luc had 3-fold more activity than 117R1 (data not shown). Addition of enhancer to this construct resulted in a 23-fold increase in activity (Fig. 10B) . Mutation of Ea did not have significant effect on the enhancer activity, whereas mutations of Eb or Ec caused about 40 and 60% reduction in c enhancer (Ϫ2866 to Ϫ2625) fused to 117R1 (see Fig. 8 for specific mutations). The Luc activity is expressed relative to that of 117enh (arbitrarily set to 100). B, As4.1 cells were transfected with plasmid 2625 containing 2625 bp of Ren-1 c 5Ј-flanking sequence and constructs containing wild-type and site-specific mutated Ren-1 c enhancer (Ϫ2866 to Ϫ2625) fused to 2625. The Luc activity is expressed relative to that of 2625enh (arbitrarily set to 100). activity, respectively. When both Eb and Ec were mutated, 86% of enhancer activity was lost. Mutations of either CRE or E-box almost completely abolished the Ren-1 c enhancer function, again, demonstrating that both the CRE motif and E-box are crucial for renin gene expression.
cAMP Responsiveness of the Ren-1 c CRE in As4.1 and JEG-3 Cells-To test whether the CRE within the Ren-1 c enhancer is the target of cAMP/PKA signal transduction pathway, As4.1 cells were transfected with constructs 2625enh and 2625enh/ mcre. Treatment of transfected cells with forskolin, an activator of adenylyl cyclase, did not cause any significant increase in luciferase activity for either plasmid (Fig. 11A) . Similar results were obtained with plasmids Enh-TA and Enh/mcre-TA containing the Ren-1 c enhancer and the CRE-mutated enhancer, respectively, inserted immediately upstream of an E1b TATA box. These results suggest that either the Ren-1 c CRE is not a functional CRE or As4.1 cells are insensitive to cAMP treatment. To test these possibilities, SSCRE, a construct containing a consensus CRE, was transfected into As4.1 cells and treated with forskolin. No induction by forskolin was observed for SSCRE, suggesting that the cAMP responsiveness is lost in As4.1 cells.
The same plasmids were also transfected into JEG-3 cells, which do not express renin but are highly responsive to cAMP. The basal transcriptional activity for 2625enh was very low in JEG-3 cells (Fig. 11B) . Moreover, mutation of the CRE within the enhancer (2625enh/mcre) did not cause any decrease in transcriptional activity, suggesting that the Ren-1 c enhancer is not functional when placed 2.6 kb upstream of the transcription start site. Thus, JEG-3 cells appear to lack components needed for high level expression of the Ren-1 c gene. Both plasmids 2625enh and 2625enh/mcre responded to forskolin treatment with about a 3-fold increase in transcriptional activity. However, this increase in activity is not mediated by the CRE. When JEG-3 cells were transfected with Enh-TA, a 7-fold induction by forskolin was observed. Mutation of the CRE in Enh-TA (Enh/mcre-TA) reduced the basal transcription by 17-fold. Forskolin only caused a 2-fold increase in luciferase activity, which is similar to forskolins effect on the E1b TATA box alone (data not shown). As a positive control, plasmid SSCRE responded to forskolin with a 20-fold increase in transcriptional activity. These results demonstrate that the Ren-1 c CRE is a functional target for the cAMP/PKA pathway when present in JEG-3 cells.
The PKA Inhibitor H-89 Reduces the Ren-1 c mRNA Level and this Inhibitory Effect Is Specifically Mediated by the CRE-It is possible that the lack of an overtly inducible cAMP response for renin expression in As4.1 cells reflects constitutive and maximal stimulation of the cAMP pathway under basal conditions. To test whether PKA might be constitutively active, we treated As4.1 cells with a PKA-specific inhibitor, H-89, and performed Northern blots to analyze the effect of H-89 on renin mRNA level. The results show that the H-89 treatment caused a more than 3-fold decrease in renin mRNA level (Fig. 12A) . These results were confirmed by transfection assays. H-89 treatment of As4.1 cells transfected with 2625enh resulted in 3-fold reduction in luciferase activity (Fig. 12B) . However, H-89 had no significant inhibitory effect on the transcriptional activity of 2625enh/mcre. To further demonstrate that the inhibitory effect of H-89 is mediated by the CRE, the construct 117R1-CRE4 containing four copies of the Ren-1 c CRE inserted upstream of the Ren-1 c promoter was tested for the H-89 response. The H-89 treatment caused a 6-fold decrease in the promoter activity of 117R1-CRE4, whereas H-89 had no effect on 117R1. These results demonstrate that the PKA-specific inhibitor H-89 is able to decrease renin gene expression in As4.1 cells and this reduction is mediated by the CRE. These results further suggest that the CRE within the Ren-1 c enhancer is a target for the cAMP/PKA pathway and that PKA is constitutively active in As4.1 cells. 
DISCUSSION
In this report, we have identified several sets of protein-DNA interaction within the mouse Ren-1 c enhancer that are required for its full activity. Sequences from Ϫ2699 to Ϫ2684 and from Ϫ2684 to Ϫ2674 were found to have the most effect on activity. The region from Ϫ2699 to Ϫ2684 contains a sequence motif homologous to the consensus CRE. Results from EMSAs using wild-type and mutated oligonucleotides have demonstrated that this CRE-like sequence motif binds As4.1 cell nuclear proteins identical with a consensus CRE. Supershift EMSAs have identified the interacting proteins as CREB and CREM, members of the CREB/ATF transcription factor family. A dominant negative CREB mutant (A-CREB) was capable of inhibiting transcription from a construct containing four copies of a Ren-1 c CRE in As4.1 cells, further suggesting that the CRE is a binding site for CREB/ATF transcription factors. An E-box motif is contained in the other critical region from Ϫ2684 to Ϫ2674. This E-box binds nuclear proteins in As4.1 cells which are specific for this motif since an excess of wild-type E-box oligonucleotide competes complex formation while a similar oligonucleotide containing a mutated E-box cannot. Competition and supershift EMSAs have demonstrated that bHLHleucine zipper transcription factors USF1/USF2 bind to this E-box. This is further supported by the binding capability of in vitro transcribed/translated USF1 to the E-box. Interestingly, USF1 has also recently been reported to bind E-box motifs in actin and osteopontin gene promoters in vascular smooth muscle (22, 23) .
Mouse renin gene expression is subject to cAMP stimulation in kidney (24) . Two regions located at Ϫ60 and Ϫ600 have been reported to confer the cAMP responsiveness. By transfecting wild-type and mutated Ren-1 c promoter constructs into embryonic kidney-derived 293 cells, which do not express renin, Tamura et al. (25) observed that the RP-2 element (Ϫ75 to Ϫ47) was capable of directing the cAMP response. EMSA demonstrated that nuclear proteins from 293 cells bound the RP-2 element and the binding activity was enhanced by pretreatment with cAMP. Our results have shown that RP-2 element corresponds to a HOX⅐PBX⅐PREP1-binding site (48) , which is critical for the Ren-1 c expression (10, 48) . HOX paralog groups 9 and 10 bind this site with high affinities (48) . A recent report by Saleh et al. (26) suggests that PKA can activate a HOX⅐PBX complex to induce transcription through recruitment of the CREB-binding protein. Thus, the cAMP response of the RP-2 element is possibly mediated by the HOX⅐PBX complex.
Horiuchi et al. (27, 28) have identified a poor consensus CRE at Ϫ600 of Ren-1 d , which overlaps a negative responsive element (NRE). A more recent report by Tamura et al. (29) has demonstrated that the oligonucleotide containing both the CRE and NRE, termed CNRE, binds LXR␣, a member of the nuclear receptor superfamily. In studies where the CNRE elements have been fused to heterologous promoters, but not the native mouse renin promoter sequence, they have identified LXR␣ as the cAMP responsive modulator of the renin gene. It remains to be seen whether this element contributes to basal and cAMPinduced mouse renin expression in vivo.
Lastly as reported here, the finding of a CREB/CREM transcription factor-binding site in the enhancer region of mouse Ren-1 c provides another potential site for cAMP regulation of renin genes. The effect of cAMP on basal renin gene expression in As4.1 cells is not readily discernible since these cells do not respond to cAMP or forskolin by increasing gene expression (Fig. 11A) (29, 50) . However, the Ren-1 c CRE was responsive to forskolin stimulation in JEG-3 cells, indicating that the CRE is functional in cAMP-responsive cells. As4.1 cells were selected by transgene-targeted oncogenesis with a Ren promoter driving SV40 T antigen, and tumor outgrowth depended on one or more additional stochastic events. It would not be surprising if a second cellular mutation were to have occurred in a signal transduction pathway (i.e. such as cAMP pathway) that leads to maximal stimulation of the enhancer, driving oncogene expression. We therefore investigated whether PKA activity is constitutive and demonstrated that, in As4.1 cells, the PKAspecific inhibitor, H-89, was able to decrease both renin mRNA level and expression of 2625enh, a construct containing the Ren-1 c enhancer. Moreover, this inhibitory effect was mediated by the CRE, suggesting that a component in cAMP pathway may be mutated in As4.1 cells to result in the constitutive activation of PKA. Constitutive activation of the cAMP pathway in tumor cells has been reported previously. These studies have shown, for example, that, in about 30 -40% growth hormone-secreting pituitary adenomas, a mutation in the Gsa gene results in constitutively active adenylyl cyclase and elevated cAMP level (see Refs. 51 and 52, for reviews).
The bHLH-leucine zipper transcription factors USF1 and USF2 were first identified as activators of the adenovirus major late promoter by binding to a USF consensus sequence containing the CACGTG E-box motif (30) . However, in addition to its consensus sequence, USF proteins have also been reported to bind other sequences, including CGCGTG (31, 32), CCCGTG (33), CAGCTG (22, 34) , CACCTG (35) , and CACATG (36, 37, 44) . We have demonstrated that USF1/USF2 binds to a CAGATG motif within the mouse Ren-1 c enhancer. Thus, USF is capable of binding to various E-box motifs to regulate gene expression.
From mutational analyses of mouse Ren-1 c enhancer, the binding sites for CREB/CREM and USF1 appear to be crucial elements. Deletion of either site results in almost complete loss of the enhancer activity and renin expression in As4.1 cells. Thus contribution of these two sites seems to lie at the foundation of the renal enhancer. To determine whether CREB and USF1 can bind cooperatively to an oligonucleotide spanning the Ren-1 c enhancer region from Ϫ2702 to Ϫ2679 bp, which contains both the CREB/CREM and USF-binding sites, we performed EMSAs using in vitro translated CREB and USF1. No cooperative binding between CREB and USF1 was observed (data not shown). The results suggest that coactivators, such as CREB-binding protein/p300 (38, 39) , may be necessary for the indirect interaction between these two transcription factors. It has been recently reported that the activation of gene promoters by USF may be mediated by CREB-binding protein/p300 (40, 41) . Interestingly, transcription of transforming growth factor-␤2 is also dependent on a CRE which binds CREB/ATF-1 and an adjacent E-box which binds USF1/USF2 (42, 43) . Mutation of either site results in 60 -80% reduction in transforming growth factor-␤2 gene expression.
By contrast with the CRE and E-box, either element Ec or Eb, which binds RAR and RXR as well as other unidentified orphan nuclear receptors (14) , contributes to enhancement to a lesser extent than either the CRE or E-box. In addition to the above elements, the renin enhancer also contains other important and as yet unidentified elements residing 5Ј to the CRE site, including regions from Ϫ2829 to Ϫ2803, Ϫ2777 to Ϫ2751, and Ϫ2738 to Ϫ2699. Deletions of these regions result in a 10-fold decrease in enhancer activity (Fig. 1) . Moreover, EMSAs indicate the As4.1 nuclear protein-DNA interactions in these regions. 3 These regions may bind tissue or cell-specific transcription factors to contribute to the highly regulated mouse renin expression. However, these elements are by themselves not sufficient to enhance basal promoter activity, sug-gesting that they may contribute to enhancer activity by interacting with CRE/E-box core enhancer elements.
A major contribution to the tissue specificity of renin expression is very likely conferred by the HOX⅐PBX-binding site that we have recently identified in the proximal promoter region, at Ϫ60 relative to the transcription start site (48) . This finding strongly implicates renin, which initiates a cascade leading to production of the growth factor and pressor substance angiotensin II, as an immediate downstream target of Class I Hox genes. Interestingly, while this site is absolutely critical for expression from the Ren-1 c gene (10, 48) , it confers no transcriptional activity as an isolated element (10) . Indeed, the situation which appears to pertain in the case of mammalian renin gene expression is highly reminiscent of recent insights gleaned from studies of downstream targets of HOX regulation in Drosophila (53) (54) (55) . Enhancers regulating expression of such target genes appear to be modular in structure. Their activity is dependent upon the obligate and synergistic integration of information from signal transduction pathways and selector genes through provision of binding sites for the nuclear effectors of signaling pathways, such as CREB, and selector genes, such as Hox. The molecular basis for the obligate synergy between the selector and signaling protein complexes in these systems is not as yet clear. Similarly, how the distal renal enhancer communicates with the critical proximal promoter element remains to be answered. It is possible that CREB/CREM proteins interact with HOX⅐PBX⅐PREP1 indirectly by binding to a common coactivator. Both CREB/CREM and HOX⅐PBX are capable of interacting with coactivaters such as CREB-binding protein/p300. Alternatively, direct protein-protein interactions between CREB/CREM/USF and HOX⅐PBX⅐PREP1 may be responsible for the high level expression of mouse Ren-1 c gene in As4.1 cells.
